Search research articles
Contact Us
Filters
Showing results (261-270 of 285) with videos related to
Page
of 29
Sort By:
Cancer Research
|
April 1, 1993
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
R J Scheper, H J Broxterman, G L Scheffer, et al.
British Journal of Cancer
|
November 1, 1991
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein
G J Schuurhuis, H J Broxterman, J H de Lange, et al.
Lancet (London, England)
|
February 9, 1999
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
J B Vermorken, A M Claessen, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients
A Baars, A M Claessen, A J van den Eertwegh, et al.
Experimental Dermatology
|
February 1, 2005
Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure
S W Spiekstra, M J Toebak, S Sampat-Sardjoepersad, et al.
Clinical and Experimental Immunology
|
April 17, 2004
Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine
P G Boelens, J C M Fonk, A P J Houdijk, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 1999
MRP3, an organic anion transporter able to transport anti-cancer drugs
M Kool, M van der Linden, M de Haas, et al.
British Journal of Cancer
|
March 31, 1999
Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
T D de Gruijl, H J Bontkes, F Peccatori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
H J Arts, D Katsaros, E G de Vries, et al.
Cancer Research
|
March 8, 2000
The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines
A B Schroeijers, A C Siva, G L Scheffer, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 285) with videos related to
Sort By:
Page
of 29
Cancer Research
|
April 1, 1993
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
R J Scheper, H J Broxterman, G L Scheffer, et al.
British Journal of Cancer
|
November 1, 1991
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein
G J Schuurhuis, H J Broxterman, J H de Lange, et al.
Lancet (London, England)
|
February 9, 1999
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
J B Vermorken, A M Claessen, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients
A Baars, A M Claessen, A J van den Eertwegh, et al.
Experimental Dermatology
|
February 1, 2005
Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure
S W Spiekstra, M J Toebak, S Sampat-Sardjoepersad, et al.
Clinical and Experimental Immunology
|
April 17, 2004
Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine
P G Boelens, J C M Fonk, A P J Houdijk, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 1999
MRP3, an organic anion transporter able to transport anti-cancer drugs
M Kool, M van der Linden, M de Haas, et al.
British Journal of Cancer
|
March 31, 1999
Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
T D de Gruijl, H J Bontkes, F Peccatori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
H J Arts, D Katsaros, E G de Vries, et al.
Cancer Research
|
March 8, 2000
The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines
A B Schroeijers, A C Siva, G L Scheffer, et al.
Page
of 29